[go: up one dir, main page]

AU2002313778A1 - Combined drug and csf removal therapies and systems - Google Patents

Combined drug and csf removal therapies and systems

Info

Publication number
AU2002313778A1
AU2002313778A1 AU2002313778A AU2002313778A AU2002313778A1 AU 2002313778 A1 AU2002313778 A1 AU 2002313778A1 AU 2002313778 A AU2002313778 A AU 2002313778A AU 2002313778 A AU2002313778 A AU 2002313778A AU 2002313778 A1 AU2002313778 A1 AU 2002313778A1
Authority
AU
Australia
Prior art keywords
systems
combined drug
csf removal
removal therapies
therapies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002313778A
Inventor
Denise F. Gottfried
Dawn Mcguire
Tom Saul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eunoe Inc
Original Assignee
Eunoe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eunoe Inc filed Critical Eunoe Inc
Publication of AU2002313778A1 publication Critical patent/AU2002313778A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
    • A61M3/0258—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped by means of electric pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0464—Cerebrospinal fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002313778A 2001-08-21 2002-08-19 Combined drug and csf removal therapies and systems Abandoned AU2002313778A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31393801P 2001-08-21 2001-08-21
US60/313,938 2001-08-21
PCT/US2002/026435 WO2003015710A2 (en) 2001-08-21 2002-08-19 Combined drug and csf removal therapies and systems

Publications (1)

Publication Number Publication Date
AU2002313778A1 true AU2002313778A1 (en) 2003-03-03

Family

ID=23217836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002313778A Abandoned AU2002313778A1 (en) 2001-08-21 2002-08-19 Combined drug and csf removal therapies and systems

Country Status (2)

Country Link
AU (1) AU2002313778A1 (en)
WO (1) WO2003015710A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001289580A1 (en) 2000-09-11 2002-03-22 Csf Dynamics A/S A fluid shunt system and a method for the treatment of hydrocephalus
ES2307396B1 (en) * 2006-09-14 2009-09-30 Fundacion Para Investigaciones Neurologicas (Fin) SYSTEMS FOR THE ELIMINATION OF NEUROTOXIC SUBSTANCES CAUSING NEURODEGENERATIVE DISEASES THROUGH THEIR SELECTIVE ATTACKING BY IMMUNOFINITY IN THE CIRCULATING CEPHALO-RAQUIDEO LIQUID.
US8435204B2 (en) 2006-10-09 2013-05-07 Neurofluidics, Inc. Cerebrospinal fluid purification system
US10850235B2 (en) 2006-10-09 2020-12-01 Minnetronix, Inc. Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow
US10632237B2 (en) 2006-10-09 2020-04-28 Minnetronix, Inc. Tangential flow filter system for the filtration of materials from biologic fluids
WO2011114260A1 (en) 2010-03-19 2011-09-22 Pfizer Inc. Cerebrospinal fluid purification system
US20150038948A1 (en) * 2013-07-31 2015-02-05 G-Tech Electronic Research & Development, LLC Apparatus and use of a neurochemisrty regulator device insertable in the cranium for the treatment of cerebral cortical disorders
WO2015049588A2 (en) * 2013-10-01 2015-04-09 Md Start Sa Systems and methods for moving and circulating fluid to treat alzheimer's disease
US11147540B2 (en) 2015-07-01 2021-10-19 Minnetronix, Inc. Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue
ES2944452T3 (en) 2015-12-04 2023-06-21 Minnetronix Inc Cerebrospinal fluid conditioning systems
CN107088257B (en) * 2017-04-27 2023-06-09 哈尔滨医科大学 A Y-type dual-purpose double-cavity and two-bag drainage device
CA3107349A1 (en) 2018-07-23 2020-01-30 Enclear Therapies, Inc. Methods of treating neurological disorders
CN113164557A (en) 2018-07-23 2021-07-23 因柯利尔疗法公司 Methods of treating neurological disorders
CN114007665B (en) 2019-04-11 2024-11-12 因柯利尔疗法公司 Method for improving cerebrospinal fluid and its device and system
US11559626B2 (en) * 2020-04-08 2023-01-24 Medtronic, Inc. Means to treat Alzheimer's disease via flushing of brain parenchyma
JP2023543868A (en) * 2020-09-29 2023-10-18 エンクリアー セラピーズ， インク． Subarachnoid fluid management methods and systems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69007465T2 (en) * 1989-10-11 1994-10-20 Baxter International Inc., Deerfield, Ill. INTEGRATED INTRACRANIAL PRESSURE MONITOR AND DRAINAGE CATHETER.
US5957912A (en) * 1998-04-16 1999-09-28 Camino Neurocare, Inc. Catheter having distal stylet opening and connector
US6193691B1 (en) * 1999-03-30 2001-02-27 Depuy Orthopaedics, Inc. Catheter system
US6913589B2 (en) * 2002-01-14 2005-07-05 Codman & Shurtleff, Inc. Multi-catheter insertion device and method

Also Published As

Publication number Publication date
WO2003015710A2 (en) 2003-02-27
WO2003015710A3 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
AU2002341959A1 (en) Drug delivery devices and methods
AU2002240275A1 (en) Methods and devices for delivering occlusion elements
AU2002244142A1 (en) Integrated medication delivery system
AU2002364897A1 (en) Imiquimod therapies
AU6271401A (en) Drug administering system and administering method
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2003230845A1 (en) Systems and methods for interventional medicine
AU2003281876A1 (en) Pharmaceutical delivery systems and methods for using same
AU2002347308A1 (en) Secure collection and delivery system
AU2002326494A1 (en) Products and drug delivery vehicles
AU2002313778A1 (en) Combined drug and csf removal therapies and systems
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
AU2002361597A1 (en) Combination spa and entertainment system
AUPR573001A0 (en) Lymphatic drug delivery system
AU2002342053A1 (en) Pancreatic cancer diagnosis and therapies
AU6196600A (en) Medication reminder system
AU2002363522A1 (en) System and method for improved computer drug design
GB0111496D0 (en) Therapeutic systems and methods
AU2002222138A1 (en) Drug delivery system
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU1955101A (en) System for interdependent integration and aggregation
AU2002210580A1 (en) Drug delivery system
AU2002319175A1 (en) System and method for managing the administration of tecommunication
AU2002329204A1 (en) Pharmaceutical detailing system
AU2002322833A1 (en) Systems and methods to facilitate the delivery of drugs

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase